Viatris帮助向全世界数百万人提供基本药品,应对全球获得保健服务的挑战。 Viatris helps deliver essential medicines to millions worldwide amid global healthcare access challenges.

世界上大约一半的人口由于收入、地理和系统障碍而无法获得基本保健,全球卫生系统因大流行性沉降、人口老化和劳动力短缺而紧张。 About half the world’s population lacks access to essential healthcare due to income, geography, and systemic barriers, with global health systems strained by pandemic fallout, aging populations, and workforce shortages. Viatris是一家设在美国的制药公司,向165多个国家(包括90%的中低收入国家)提供卫生组织基本药品清单上的240多种药品——几乎占总数的一半。 Viatris, a U.S.-based pharmaceutical company, supplies over 240 medicines on the WHO Essential Medicines List—nearly half the total—to more than 165 countries, including 90% of low- and middle-income nations. 该公司强调一个弹性强、多样化的供应链,能够对需求激增作出迅速反应,在260%的激增之后,它在新西兰提供了替代更年期治疗。 The company emphasizes a resilient, diversified supply chain, enabling rapid response to demand spikes, as seen when it provided alternative menopause treatments in New Zealand after a 260% surge. Viatris通过与各国政府、保健提供者和全球组织合作,支持扩大获得保健服务的机会、提高质量和促进保健可持续性的政策和制度。 Through partnerships with governments, health providers, and global organizations, Viatris supports policies and systems that expand access, improve quality, and promote sustainability in healthcare.